This Is Why Omeros Corporation Shares Are Rocketing 33% Higher Today

This Is Why Omeros Corporation Shares Are Rocketing 33% Higher Today

Despite already rewarding investors with more than a 100% return this year, shares of Omeros Corporation (NASDAQ: OMER) are charging 33.3% higher at 1:45 p.m. EST Friday following the release of its third-quarter financials.

Omeros is riding high on continued revenue growth for its only approved medicine, Omidria. Omidria, which is used in cataract and other lens replacement procedures, generated sales of $21.7 million last quarter, up 26% from the second quarter and 92% year over year.

Image source: Getty Images.

Continue reading

Source: Fool.com